Research Studies

Title: Duration of effect of Bimatoprost SR in participants with Open-angle glaucoma or Ocular hypertension.

Sponsor: Allergan

Purpose: A phase 3b study to Evaluate the Duration of Effect of Bimatoprost SR in participants with Open-Angle Glaucoma or Ocular Hypertension

Enrollment Status: Open at all our locations

Title: An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients With Open Angle Glaucoma or Ocular Hypertension

Sponsor: Allergan

Purpose: Evaluation of the long-term safety and efficacy of Bimatoprost SR in patients with open-angle glaucoma or ocular hypertension who completed 1 of the 4 Phase 3 Bimatoprost SR studies and received Bimatoprost SR.

Enrollment Status: Open at all our locations

Title: A Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

Sponsor: Glaukos

Purpose: A Phase 3 Study to compare the safety and efficacy of intraocular implants containing travoprost at two different elution rates versus Timolol Maleate Ophthalmic Solution, 0.5% (timolol) in reducing elevated intraocular pressure in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Enrollment Status: Open at all our locations

Title: A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension

Sponsor: Allergen

Purpose: A phase 3 study evaluating the efficacy and safety of Bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension versus Selective Laser Trabeculoplasty. The study includes a 14-month treatment.

Enrollment Status: Open at all our locations

Title: A GLD122c‐C001 Post Approval Study of the CyPass System in Patients with Primary Open Angle Glaucoma Undergoing Cataract Surgery

Sponsor: Novartis

Purpose: A Prospective, Multicenter, Study Evaluating the Safety and Efficacy of CyPass in patients with Open-Angle Glaucoma or Ocular Hypertension undergoing Cataract Surgery.

Enrollment Status: Open at all our locations

Title: Lyrica Prebabalin A0081096 Study

Sponsor: Pfizer

Purpose: A phase 4 testing in Patients with Partial Seizures Receiving Either Lyrica or Placebo

Enrollment Status: Closed

Title: Evaluating the Safety and Efficacy of OTX-TP (Travoprost Intracanalicular plugs) in the Treatment of Subjects with Open-Angle Glaucoma or Ocular Hypertension

Sponsor: Ocular Therapeautix, Inc.

Purpose: A Prospective, Multicenter, Randomized, Parallel-Arm, Double Masked, Vehicle Controlled Phase 3a Study Evaluating the Safety and Efficacy of OTX-TP in patients with Open-Angle Glaucoma or Ocular Hypertension

Enrollment Status: Closed